Alamar Biosciences(ALMR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ALMR Alamar Biosciences

Closed 08-24 16:00:00 EDT

32.70

-1.54

-4.50%

盘后32.80

+0.10+0.31%

19:30 EDT

High34.50	Low32.06	Vol303.72K
Open34.07	D1 Closing34.24	Amplitude7.12%
Mkt Cap2.27B	Tradable Cap423.06M	Total Shares69.31M
T/O10.04M	T/O Rate2.35%	Tradable Shares12.94M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ALMR","market":"US","secType":"STK","nameCN":"Alamar Biosciences","latestPrice":32.7,"timestamp":1787601600000,"preClose":34.24,"halted":0,"volume":303719,"hourTrading":{"tag":"盘后","latestPrice":32.8,"preClose":32.7,"latestTime":"19:30 EDT","volume":3360,"amount":109995.0401,"timestamp":1787614207336,"change":0.1,"changeRate":0.003058,"amplitude":0.003058},"delay":0,"changeRate":-0.04497663551401866,"floatShares":12937500,"shares":69311200,"eps":-0.716,"marketStatus":"Closed","change":-1.54,"latestTime":"08-24 16:00:00 EDT","open":34.07,"high":34.5,"low":32.061,"amount":10037979.768180002,"amplitude":0.071232,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.716,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":5,"adr":0,"listingDate":1776398400000,"exchange":"NASDAQ","adjPreClose":34.24,"preHourTrading":{"tag":"盘前","latestPrice":34.74,"preClose":34.24,"latestTime":"07:41 EDT","volume":20,"amount":691.1,"timestamp":1787571691393,"change":0.5,"changeRate":0.014603,"amplitude":0.067757},"postHourTrading":{"tag":"盘后","latestPrice":32.8,"preClose":32.7,"latestTime":"19:30 EDT","volume":3360,"amount":109995.0401,"timestamp":1787614207336,"change":0.1,"changeRate":0.003058,"amplitude":0.003058},"volumeRatio":0.960847},"requestUrl":"/m/hq/s/ALMR/wiki","defaultTab":"wiki","newsList":[{"id":"2658917839","title":"Alamar Biosciences Price Target Raised to $32.00/Share from $28.00 by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2658917839","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658917839?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:51","pubTimestamp":1786470660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALMR/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SF","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658122669","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2658122669","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658122669?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:33","pubTimestamp":1786469637,"startTime":"0","endTime":"0","summary":"Quantum  swung to non-GAAP adjusted net income in fiscal Q1, while revenue exceeded the company's own guidance range, it said late Monday.Shares soared nearly 61% amid a surge in intraday trading volume to over 11.8 million from a daily average of about 1.14 million.NIQ Global Intelligence  reported Q2 adjusted earnings late Monday, swinging from a loss a year earlier. Revenue grew faster than the market had forecast.Shares surged 41% as intraday trading volume jumped to over 6.01 million from a daily average of roughly 1.57 million.Alamar Biosciences  reported a narrower Q2 net loss and sales above consensus late Monday.Shares advanced 34%, with intraday trading volume rising to more than 667,000 from the stock's daily average of about 286,000.Price: 18.65, Change: +6.87, Percent Change: +58.32","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4121","QMCO","BK4602","NIQ","ALMR","BK4170","BK4009"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658912131","title":"Alamar Biosciences Stock Soars, CEO Says Company Is Well-Positioned to Sustain Upcoming Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2658912131","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658912131?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:25","pubTimestamp":1786469146,"startTime":"0","endTime":"0","summary":"Alamar Biosciences expands its Alzheimer’s data partnership, adds 86,000 samples and reports Q2 sales growth of 82% year-over-year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/26/08/61120052/alamar-biosciences-stock-soars-ceo-says-company-is-well-positioned-to-sustain-upcoming-momentum","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BETZ","ALMR","ODDS","BK4121","RSI","BK4150","ODDZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658919998","title":"Alamar Biosciences up over 18%, on Track for Record High Close and Record Percent Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=2658919998","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658919998?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:42","pubTimestamp":1786459320,"startTime":"0","endTime":"0","summary":"Alamar Biosciences, Inc.  is currently at $33.24, up $5.26 or 18.77%--Would be new all-time closing high --Would be largest percent increase on record --Currently up seven of the past nine days--Up 31.09% month-to-date--Would be a new 52-week closing high--Up 74.15% from its 52-week closing low of $19.09 on May 26, 2026--Traded as high as $33.59; new all-time intraday high --Up 20.01% at today's intraday high; largest intraday percent increase on record All data as of 10:40:08 AM ETSource: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658990131","title":"BofA Adjusts Price Target on Alamar Biosciences to $31 From $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2658990131","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658990131?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:13","pubTimestamp":1786450433,"startTime":"0","endTime":"0","summary":"Alamar Biosciences (ALMR) has an average rating of buy and mean price target of $33.40, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997656","title":"Alamar Biosciences price target raised to $32 from $28 at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997656","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997656?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:42","pubTimestamp":1786448552,"startTime":"0","endTime":"0","summary":"Stifel raised the firm’s price target on Alamar Biosciences (ALMR) to $32 from $28 and keeps a Buy rating on the shares after the company posted a ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-price-target-raised-to-32-from-28-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-price-target-raised-to-32-from-28-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658998279","title":"U.S. Research Roundup-Accendra Health, Celestica, Sionna Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2658998279","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658998279?lang=en_us&edition=fundamental","pubTime":"2026-08-11 16:10","pubTimestamp":1786435846,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna TherapeuticsAug 11 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL8N4480HI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CON","CRC","BA","CNC","BKV","RXL","ABBV","ALL","ACH","ITA","AMAT","ALMR","AXSM","ASTH","SECZ","CEVA","TPYP","CHMI","IEO","CODI","COR","ORBX","BBY","DRTS","IYH","COP","ASPN","MO","CLS","AAON","AFG","ANF","LNG","AFL","AAOI","COGT","APP","BOEU","CLBK","TGT","FTXH","IGE","ASTS","BBIO","ACVA","AGL","OILT","BKD","BWMN","CENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658952467","title":"Alamar Biosciences Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658952467","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658952467?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:38","pubTimestamp":1786397923,"startTime":"0","endTime":"0","summary":"Alamar Biosciences Inc reports results for the quarter ended June 30 - Earnings SummaryAlamar Biosciences IncALMR.OQreported a quarterly adjusted loss of 22 cents per share for the quarter ended June ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N44723J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658954341","title":"Alamar Biosciences Outlook FY Revenue $116 Mln-$120 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954341","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954341?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:53","pubTimestamp":1786395213,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXD7W9SP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658039951","title":"Alamar Biosciences reports Q2 EPS (22c), consensus (32c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658039951","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658039951?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:35","pubTimestamp":1786394141,"startTime":"0","endTime":"0","summary":"Reports Q2 revenue $29.4M, consensus $25.94M. “We delivered a strong second quarter with consumable revenue growing nearly 150% year-over-year,” sa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-reports-q2-eps-22c-consensus-32c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-reports-q2-eps-22c-consensus-32c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658951055","title":"Alamar Biosciences sees FY26 revenue $116M-$120M, consensus $113.22M","url":"https://stock-news.laohu8.com/highlight/detail?id=2658951055","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658951055?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:35","pubTimestamp":1786394137,"startTime":"0","endTime":"0","summary":"16:32 EDT Alamar Biosciences (ALMR) sees FY26 revenue $116M-$120M, consensus $113.22M Published first on TheFly – the ultimate source for real-time...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-sees-fy26-revenue-116m-120m-consensus-113-22m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-sees-fy26-revenue-116m-120m-consensus-113-22m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658495168","title":"Alamar Biosciences Q2 2026 Net Loss Widens to $13.2 Million; Revenue Rises 82% to $29.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658495168","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658495168?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:30","pubTimestamp":1786393805,"startTime":"0","endTime":"0","summary":"Alamar Biosciences Q2 2026 net loss widens to $13.2 million; revenue rises 82% to $29.4 millionAlamar Biosciences posted Q2 revenue of $29.4 million, up 82% year over year.Net loss widened to $13.2 mi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL7Yf7FM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658597819","title":"Earnings Flash (ALMR) Alamar Biosciences Posts Q2 Loss Per Share $0.22, vs. FactSet Est of $0.31 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658597819","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658597819?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:18","pubTimestamp":1786393122,"startTime":"0","endTime":"0","summary":"Earnings Flash (ALMR) Alamar Biosciences Posts Q2 Loss Per Share $0.22, vs. FactSet Est of $0.31 Loss","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658295919","title":"Alamar Biosciences Q2 EPS $(0.22) Beats $(0.33) Estimate, Sales $29.427M Beat $25.940M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658295919","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658295919?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:13","pubTimestamp":1786392790,"startTime":"0","endTime":"0","summary":"Alamar Biosciences Q2 EPS $(0.22) Beats $(0.33) Estimate, Sales $29.427M Beat $25.940M Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/ALMR","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Alamar Biosciences Q2 EPS $(0.22) Beats $(0.33) Estimate, Sales $29.427M Beat $25.940M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658695647","title":"Alamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates Ventures","url":"https://stock-news.laohu8.com/highlight/detail?id=2658695647","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658695647?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:03","pubTimestamp":1786392180,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA4Z3MS6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALMR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657215316","title":"Alamar Biosciences Inc Expected to Post a Loss of 33 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657215316","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657215316?lang=en_us&edition=fundamental","pubTime":"2026-08-08 05:56","pubTimestamp":1786139767,"startTime":"0","endTime":"0","summary":"Alamar Biosciences Inc <ALMR.OQ> expected to post a loss of33cents a share - Earnings PreviewAlamar Biosciences IncALMR.OQALMR.Ois expected to  report resultson August 10 for the period ending June 30 2026The Fremont California-based  company is expected to report revenue of $25.94 million, according to the mean estimate from 5 analysts, based on LSEG data.LSEG's mean analyst estimate for Alamar Biosciences Inc is for a loss of 33 cents per share.The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 4 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\"The average consensus recommendation for the advanced medical equipment & technology peer group is also \"Buy\".Wall Street's median 12-month price target for Alamar Biosciences Inc is $32.00, about 13.9% above its last closing price of $28.10This summary was machine generated August 7 at 21:56 GMT.  All figures in US dollars unless otherwise stated.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4442MD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657614462","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2657614462","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657614462?lang=en_us&edition=fundamental","pubTime":"2026-08-07 18:00","pubTimestamp":1786096800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. ACM Research Inc. Class A                       2Q       .42       BMO. Algonquin Power & Utilities Corp.                2Q       .03   6:30 AM. Alpha Metallurgical Resources Inc.               2Q      (.43)  7:30 AM. Construction Partners Inc. Class A              3Q      1.01       BMO. Kimbell Royalty Partners LP                      2Q       .23   7:00 AM. Park Hotels & Resorts Inc.                        2Q       .25       AMC. Plains All American Pipeline L.P.                2Q       .38   7:30 AM. Plains GP Hldgs LP Class A                      2Q       .46   7:30 AM. Rapid Micro BioSyss Inc. Class A                2Q      (.24)      BMO. Spectrum Brands Hldgs Inc.                       3Q      1.46   6:30 AM","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELVA","AMTM","BWMN","CBLL","EMBC","AIOT","EMA","CIB","CRC","ANIP","DMAC","ACHR","AMR","CTEV","B","ACVA","BTDR","ACH","APEI","BKD","DCGO","ACM","AXSM","ACMR","ASTS","CAMT","ATMU","AAON","ANAB","ARQ","BBIO","DCBO","AQN","DH","CNDT","BZH","CODI","ALMR","UA","BODI","ALC","CNTY","BCSF","CGC","CCAP","CEVA","DCH","CLMT","ELTX","CECO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178681101","title":"Earning Preview: Alamar Biosciences Q2 revenue is expected to decrease by 0.37%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1178681101","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178681101?lang=en_us&edition=fundamental","pubTime":"2026-08-03 10:30","pubTimestamp":1785724253,"startTime":"0","endTime":"0","summary":"Abstract Alamar Biosciences will report second-quarter 2026 financial results on August 10, 2026 Post-Mkt, and investors are focused on top-line durability, margin trajectory, and whether losses...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Earning Preview: Alamar Biosciences Q2 revenue is expected to decrease by 0.37%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199227711","title":"Goldman Sachs-Backed Immunotherapy Pioneer Attovia (ATTO.US) Heads to Nasdaq: Targeting $212.5 Million in Top Funding, Adding Fuel to Biotech IPO Boom","url":"https://stock-news.laohu8.com/highlight/detail?id=1199227711","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199227711?lang=en_us&edition=fundamental","pubTime":"2026-07-30 12:00","pubTimestamp":1785384038,"startTime":"0","endTime":"0","summary":"With biotech IPOs delivering an average 55% return, outpacing the AI sector and emerging as the top performer in 2026 U.S. stock markets, another clinical-stage biopharmaceutical company is joining...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770308.USD","LU2237443895.HKD","LU2471134952.CNY","BK4127","ALMR","GSX","LU0742534661.SGD","LU2471134879.HKD","LU2237443465.HKD","LU2237443978.SGD","LU0048573561.USD","LU1868837136.USD","IE0034235188.USD","IE00BFXG1179.USD","LU1868836757.USD","GS","LU0868494617.USD","IE00BSNM7G36.USD","BK4121","LU1668664300.SGD","LU0942090050.USD","IE00B19Z3B42.SGD","IE0004086264.USD","LU2471134796.USD","LU1868836914.USD","LU1868837300.USD","ATTO","BK4585","LU1804176565.USD","LU0251131958.USD","LU2237443549.SGD","LU0061475181.USD","BK4533","LU0868494708.USD","LU1868836591.USD","LU1894683264.USD","LU2237438978.USD","LU2750360997.AUD","LU2237443382.USD","IE0002270589.USD","BK4516","BK4552","BK4588","LU2750360641.GBP","BK4550","IE0004091025.USD","LU0345770993.USD","LU1791807156.HKD","LU2471134523.USD","LU2237443622.USD","LU0096364046.USD","LU0106831901.USD","LU2265009873.SGD","BK4226","BK4504","BK4143","IE00B19Z3581.USD","LU1894683348.USD","LU0251142724.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655368908","title":"Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome","url":"https://stock-news.laohu8.com/highlight/detail?id=2655368908","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655368908?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:12","pubTimestamp":1785269520,"startTime":"0","endTime":"0","summary":"Expanded panel advances the understanding of immune system across translational and clinical research in cancer, cardiovascular and metabolic diseases, autoimmune diseases and aging Highly sensitive m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/28/3334730/0/en/Alamar-Biosciences-Launches-NULISAseq-Immune-340-Panel-for-Comprehensive-Profiling-of-the-Immune-Proteome.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alamarbio.com","stockEarnings":[{"period":"1week","weight":0.0326},{"period":"1month","weight":0.3631},{"period":"3month","weight":0.7069},{"period":"6month","weight":1.0141},{"period":"ytd","weight":1.0141}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Alamar Biosciences, Inc. was incorporated in Delaware on May 7, 2018, and is headquartered in Fremont, California. The company is a commercial-stage proteomics company dedicated to establishing the gold standard in protein detection and analysis. It offers the proprietary NULISA platform, which enables \"precision proteomics\" by detecting low-abundance protein biomarkers in non-invasive biofluids with ultra-high sensitivity, high specificity, flexible multiplexing, broad dynamic range, and automation. The company provides integrated solutions comprising instruments, consumables, and analytical software for discovery, translational research, and diagnostic development.","exchange":"NASDAQ","name":"Alamar Biosciences","nameEN":"Alamar Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alamar Biosciences(ALMR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Alamar Biosciences(ALMR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Alamar Biosciences,ALMR,Alamar Biosciences股票,Alamar Biosciences股票老虎,Alamar Biosciences股票老虎国际,Alamar Biosciences行情,Alamar Biosciences股票行情,Alamar Biosciences股价,Alamar Biosciences股市,Alamar Biosciences股票价格,Alamar Biosciences股票交易,Alamar Biosciences股票购买,Alamar Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alamar Biosciences(ALMR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Alamar Biosciences(ALMR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}